Tags
- A
- Advanced
- Americans
- An
- Approximately
- Benefit
- Be Used To
- Body
- Boosts
- Califano
- California
- Cancer
- Cancer Cell
- Cancer patients
- Cancer research
- Cancer types
- Cell
- Cells
- CEO
- Clinical
- Clinical trial
- Cohen
- Communication
- Courtesy
- Demonstration
- Destroy
- Diagnosis
- Die
- Disease
- Doctor
- Doctors
- Durability
- ERBB3
- Estimation
- Ezra Cohen
- Fight
- Follow-on
- Follow-on funding
- Grant
- Group action
- Gutkind
- Head and neck anatomy
- Head and neck cancer
- Health
- Helps
- If
- Immune
- Immune system
- Immunotherapy
- Immunotherapy resistance
- Impact
- Incredible
- Initial
- Initiation
- Innovation
- Invest
- Investment
- J
- Joseph A. Califano Jr.
- Leaves
- Limited options
- Lymph
- Lymph node
- Medical
- Medical Center
- Medicine
- Metformin
- Most
- National Institute
- National Institutes of Health
- Nature
- Nature Communications
- New
- Node
- Option
- Options
- Patient
- Philanthropy
- Poor
- Poor prognosis
- Portland
- Preservation
- Prognosis
- Promise
- Protein
- Providence Hospital
- Publishing
- Research
- Research and innovation
- Researcher
- Resistance
- Revolution
- San Diego
- School
- School of Medicine
- Secure
- Sensor
- Short
- Short Time
- Specific
- Success
- Swift
- Targeting
- The body
- The Immune
- The national
- Therapy
- The Swift
- The Understanding
- Three
- Time period
- Treating
- Trial
- Trials
- Turn
- UC San Diego School of Medicine
- UCSD
- Understanding
- United State
- University
- University of California
- University of California, San Diego